Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2019 | Design and Synthesis of 1,2-Bis(hydroxymethyl)pyrrolo[2,1- a]phthalazine Hybrids as Potent Anticancer Agents that Inhibit Angiogenesis and Induce DNA Interstrand Cross-links. | Chang, SM; Jain, V; Chen, TL; Patel, AS; Pidugu, HB; Lin, YW; Wu, MH; Huang, JR; Wu, HC; Shah, A; Su, TL; Lee, TC | Journal of medicinal chemistry 62(5), 2404-2418 | | | |
2011 | Design, synthesis and antitumor evaluation of phenyl N-mustard-quinazoline conjugates. | Marvania, B; Lee, PC; Chaniyara, R; Dong, H; Suman, S; Kakadiya, R; Chou, TC; Lee, TC; Shah, A; Su, TL | Bioorganic & medicinal chemistry 19(6), 1987-1998 | | | |
2011 | Design, synthesis, and biological evaluation of novel water-soluble N-mustards as potential anticancer agents. | Kapuriya, N; Kakadiya, R; Dong, H; Kumar, A; Lee, PC; Zhang, X; Chou, TC; Lee, TC; Chen, CH; Lam, K; Marvania, B; Shah, A; Su, TL | BIOORGANIC & MEDICINAL CHEMISTRY 19(1), 471-485 | | | |
2013 | Determination of tissue distribution of potent antitumor agent ureidomustin (BO-1055) by HPLC and its pharmacokinetic application in rats. | Chien, SI; Yen, JC; Kakadiya, R; Chen, CH; Lee, TC; Su, TL; Tsai, TH | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 917-918, 62-70 | | | |
2002 | Development of DNA topoisomerase II-mediated anticancer agents, 3-(9-acridinylamino)-5-hydroxymethylanilines (AHMAs) and related compounds. | Su, TL | Current medicinal chemistry 9(18), 1677-1688 | | | |
2021 | Discovery of Oral Anticancer 1,2-Bis(hydroxymethyl)benzo[g]pyrrolo[2,1-a]phthalazine Hybrids That Inhibit Angiogenesis and Induce DNA Cross-Links | Chen, TL; Patel, AS; Jain, V; Kuppusamy, R; Lin, YW; Hou, MH; Su, TL; Lee, TC | Journal of Medicinal Chemistry 64(17), 12469-12486 | | | |
1983 | Distribution, metabolism, and excretion of 1-(2-fluoro-2-deoxy-beta-D- arabinofuranosyl)thymine and 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5- iodocytosine. | Philips, FS; Feinberg, A; Chou, TC; Vidal, PM; Su, TL; Watanabe, KA; Fox, JJ | Cancer research 43(8), 3619-27 | | | |
1996 | DNA interaction and topoisomerase II inhibition by the antitumor agent 3'-(9-acridinylamino)-5'-hydroxymethylaniline and derivatives | Scarborough, A; Su, TL; Leteutre, FF; Pommier, Y; Chou, TC | BIOORGANIC CHEMISTRY 24 (3) , 229-241 | | | |
2011 | Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response. | Chu, PM; Chiou, SH; Su, TL; Lee, YJ; Chen, LH; Chen, YW; Yen, SH; Chen, MT; Chen, MH; Shih, YH; Tu, PH; Ma, HI | Radiation Oncology 6, 7 | | | |
2010 | Glyfoline induces mitotic catastrophe and apoptosis in cancer cells. | Wu, YC; Yen, WY; Ho, HY; Su, TL; Yih, LH | International Journal of Cancer 126(4), 1017-1028 | | | |
1990 | Inhibitory effects of isoquinoline-type alkaloids on leukemic cell growth and macromolecule biosynthesis. | Tzeng, CC; Wu, YC; Su, TL; Watanabe, KA; Lu, ST; Chou, TC | Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences 6(2), 58-65 | | | |
1998 | Isolation and identification of novel protein kinase genes from the round-spotted pufferfish(Tetraodon fluviatilis) genomic DNA | Chou, CM; Lin, WC ; Leu, JH; Su, TL; Chou, CK; Huang, CJ | Journal of biomedical science 5(2), 127-134 | | | |
2012 | Multidrug-resistant cells overexpressing P-glycoprotein are susceptible to DNA crosslinking agents due to attenuated Src/nuclear EGFR cascade-activated DNA repair activity | Lee, PC; Lee, HJ; Kakadiya, R; Sanjiv, K; Su, TL; Lee, TC | Oncogene | | | |
2003 | New analogues of AHMA as potential antitumor agents: synthesis and biological activity. | Chang, JY; Lin, CF; Pan, WY; Bacherikov, V; Chou, TC; Chen, CH; Dong, H; Cheng, SY; Tasi, TJ; Lin, YW; Chen, KT; Chen, LT; Su, TL | Bioorganic & medicinal chemistry 11(23), 4959-4969 | | | |
2003 | Non-classical antifolates, 5-(N-phenylpyrrolidin-3-yl)-2,4,6-triaminopyrimidines and 2,4-Diamino-6(5H)-oxopyrimidines, synthesis and antitumor studies. | Huang, YL; Lin, CF; Lee, YJ; Li, WW; Chao, TC; Bacherikov, VA; Chen, KT; Chen, CM; Su, TL | Bioorganic & medicinal chemistry 11(1), 145-57 | | | |
2011 | Novel 2-substituted quinolin-4-yl-benzenesulfonate derivatives: synthesis, antiproliferative activity, and inhibition of cellular tubulin polymerization. | Kakadiya, R; Wu, YC; Dong, H; Kuo, HH; Yih, LH; Chou, TC; Su, TL | ChemMedChem 6(6), 1119-1129 | | | |
2011 | Novel bifunctional alkylating agents, 5,10-dihydropyrrolo[1,2-b]isoquinoline derivatives, synthesis and biological activity. | Chaniyara, R; Kapuriya, N; Dong, H; Lee, PC; Suman, S; Marvania, B; Chou, TC; Lee, TC; Kakadiya, R; Shah, A; Su, TL | Bioorganic & medicinal chemistry 19(1), 275-286 | | | |
2009 | Novel DNA-directed alkylating agents: design, synthesis and potent antitumor effect of phenyl N-mustard-9-anilinoacridine conjugates via a carbamate or carbonate linker. | Kapuriya, N; Kapuriya, K; Dong, H; Zhang, X; Chou, TC; Chen, YT; Lee, TC; Lee, WC; Tsai, TH; Naliapara, Y; Su, TL | Bioorganic & medicinal chemistry 17(3), 1264-1275 | | | |
1983 | Nucleosides. 123. Synthesis of antiviral nucleosides: 5-substituted 1-(2-deoxy-2-halogeno-beta-D-arabinofuranosyl)cytosines and -uracils. Some structure-activity relationships. | Watanabe, KA; Su, TL; Klein, RS; Chu, CK; Matsuda, A; Chun, MW; Lopez, C; Fox, JJ | Journal of medicinal chemistry 26(2), 152-6 | | | |
1984 | Nucleosides. 129. Synthesis of antiviral nucleosides: 5-alkenyl-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracils. | Watanabe, KA; Su, TL; Reichman, U; Greenberg, N; Lopez, C; Fox, JJ | Journal of medicinal chemistry 27(1), 91-94 | | | |